John Whang

John Whang, MD, currently serves as the Chief Medical Affairs Officer at BridgeBio, a position held since October 2023. Prior experience includes roles as Vice President of Medical Affairs at Bristol Myers Squibb from May 2021 to August 2023, and Head of Integrated Evidence, Internal Medicine at Johnson & Johnson from October 2017 to April 2021. Additionally, John worked as Executive Director of US Medical at Amgen from September 2014 to 2016, and as President and Chief Medical Officer at Real Endpoints from June 2012 to April 2014. Earlier in their career, John was a Senior Consultant at McKinsey & Company from 2009 to 2012. John obtained a Doctor of Medicine degree from Columbia University Vagelos College of Physicians and Surgeons and holds an AB from Harvard University.